Literature DB >> 14704726

Clinical decision-making in hypertension using an automated (BpTRU) measurement device.

J W Graves1, C Nash, K Burger, K Bailey, S G Sheps.   

Abstract

Mercury sphygmomanometers are being removed from clinical practice in the United States due to environmental concerns about mercury toxicity. Accurate blood pressure measurement is central to high-quality hypertension management. In this study of 106 patients, the BpTRU(TM) device was compared to nurse blood pressure measurements that complied with all the JNC VII/American Heart Association guidelines in evaluation of a random casual blood pressure. The intermethod difference in systolic blood pressure was +1.8+/-5.1 mmHg, and for diastolic blood pressure it was 4.8+/-5.1 mmHg (both P<0.001). For the primary study end point of clinical decision-making, there was 92% (97/106) agreement between the hypertension nurse specialist and the BpTRU (kappa 0.8280, 95% confidence interval, 0.721-0.9350). The oscillometric blood pressure measurement with the BpTRU is recommended as a replacement for poorly performed auscultatory blood pressure measurement in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14704726     DOI: 10.1038/sj.jhh.1001626

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  20 in total

Review 1.  Clinical Implications of Different Blood Pressure Measurement Techniques.

Authors:  Paul Drawz
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

Review 2.  Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.

Authors:  Paul Muntner; Paula T Einhorn; William C Cushman; Paul K Whelton; Natalie A Bello; Paul E Drawz; Beverly B Green; Daniel W Jones; Stephen P Juraschek; Karen L Margolis; Edgar R Miller; Ann Marie Navar; Yechiam Ostchega; Michael K Rakotz; Bernard Rosner; Joseph E Schwartz; Daichi Shimbo; George S Stergiou; Raymond R Townsend; Jeff D Williamson; Jackson T Wright; Lawrence J Appel
Journal:  J Am Coll Cardiol       Date:  2019-01-29       Impact factor: 24.094

Review 3.  Utility of ambulatory blood pressure monitoring in children and adolescents.

Authors:  John W Graves; Mohammed Mahdi Althaf
Journal:  Pediatr Nephrol       Date:  2006-07-06       Impact factor: 3.714

Review 4.  Is it possible to manage hypertension and evaluate therapy without ambulatory blood pressure monitoring?

Authors:  William B White; Spyridoula Maraka
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

5.  MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): a review & study protocol.

Authors:  Kimberly C Blom; Sasha Farina; Yessica-Haydee Gomez; Norm R C Campbell; Brenda R Hemmelgarn; Lyne Cloutier; Donald W McKay; Martin Dawes; Sheldon W Tobe; Peter Bolli; Mark Gelfer; Donna McLean; Gillian Bartlett; Lawrence Joseph; Robin Featherstone; Ernesto L Schiffrin; Stella S Daskalopoulou
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 6.  Managing hypertension with ambulatory blood pressure monitoring.

Authors:  William B White; Vinay Gulati
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

Review 7.  Automated office blood pressure measurement in primary care.

Authors:  Martin G Myers; Janusz Kaczorowski; Martin Dawes; Marshall Godwin
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 8.  Management of hypertension in chronic kidney disease.

Authors:  Raymond R Townsend; Sandra J Taler
Journal:  Nat Rev Nephrol       Date:  2015-07-28       Impact factor: 28.314

9.  Screening for hypertension annually compared with current practice.

Authors:  Gregory M Garrison; Sara Oberhelman
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

Review 10.  BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols.

Authors:  Paul E Drawz; Joachim H Ix
Journal:  J Am Soc Nephrol       Date:  2017-10-19       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.